Serveur d'exploration sur le saule

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Vascular protection of salicin on IL-1β-induced endothelial inflammatory response and damages in retinal endothelial cells.

Identifieur interne : 000452 ( Main/Corpus ); précédent : 000451; suivant : 000453

Vascular protection of salicin on IL-1β-induced endothelial inflammatory response and damages in retinal endothelial cells.

Auteurs : Yu Song ; Xia Tian ; Xuehong Wang ; Hui Feng

Source :

RBID : pubmed:31106593

English descriptors

Abstract

Retinal endothelial cells (RECs) are involved in many ocular diseases such as age-related macular degeneration (AMD) and diabetic retinopathy. Salicin is the major ingredient of willow bark extract, and it has been shown to be a potent anti-inflammatory agent. We aim to explore whether salicin has a vascular protective effect in RECs. Our data indicate that the presence of salicin in RECs culture media ameliorates interleukin-1β (IL-1β)-induced cellular reactive oxygen species (ROS) production and NADPH oxidase 4 (NOX-4) expression. At the cellular level, salicin attenuates IL-1β-induced mitochondrial injury as revealed by its preservation on mitochondrial membrane potential (MMP). Furthermore, salicin inhibits IL-1β-induced production of pro-inflammatory cytokines such as tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and monocyte chemoattractant protein-1 (MCP-1), vascular adhesion molecules such as intercellular cell adhesion molecule-1 (iCAM-1) and vascular cell adhesion molecule 1 (VCAM-1), and high-mobility group protein 1 (HMGB-1). On the other hand, salicin recovers IL-1β-induced reduction of endothelial nitric oxide synthase (eNOS) and nitric oxide (NO) release. The presence of salicin significantly reduces the IL-1β-induced release of lactate dehydrogenase (LDH), indicating that it mitigates cytokine caused cytotoxicity. Mechanistically, we show that salicin suppresses IL-1β-induced activation of the nuclear factor-kappa B (NF-κB) signaling as revealed by its suppression on nuclear p65 protein and transfected NF-κB promoter. Collectively, our study demonstrates by multiple facets of its mechanisms that salicin is a protective agent in retinal endothelial cells. These results imply its potential use in therapeutic usage of retinal disease.

DOI: 10.1080/21691401.2019.1608220
PubMed: 31106593

Links to Exploration step

pubmed:31106593

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Vascular protection of salicin on IL-1β-induced endothelial inflammatory response and damages in retinal endothelial cells.</title>
<author>
<name sortKey="Song, Yu" sort="Song, Yu" uniqKey="Song Y" first="Yu" last="Song">Yu Song</name>
<affiliation>
<nlm:affiliation>a Department of ophthalmology, Weihai Central hospital , Weihai , China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Tian, Xia" sort="Tian, Xia" uniqKey="Tian X" first="Xia" last="Tian">Xia Tian</name>
<affiliation>
<nlm:affiliation>a Department of ophthalmology, Weihai Central hospital , Weihai , China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Wang, Xuehong" sort="Wang, Xuehong" uniqKey="Wang X" first="Xuehong" last="Wang">Xuehong Wang</name>
<affiliation>
<nlm:affiliation>a Department of ophthalmology, Weihai Central hospital , Weihai , China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Feng, Hui" sort="Feng, Hui" uniqKey="Feng H" first="Hui" last="Feng">Hui Feng</name>
<affiliation>
<nlm:affiliation>a Department of ophthalmology, Weihai Central hospital , Weihai , China.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2019">2019</date>
<idno type="RBID">pubmed:31106593</idno>
<idno type="pmid">31106593</idno>
<idno type="doi">10.1080/21691401.2019.1608220</idno>
<idno type="wicri:Area/Main/Corpus">000452</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000452</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Vascular protection of salicin on IL-1β-induced endothelial inflammatory response and damages in retinal endothelial cells.</title>
<author>
<name sortKey="Song, Yu" sort="Song, Yu" uniqKey="Song Y" first="Yu" last="Song">Yu Song</name>
<affiliation>
<nlm:affiliation>a Department of ophthalmology, Weihai Central hospital , Weihai , China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Tian, Xia" sort="Tian, Xia" uniqKey="Tian X" first="Xia" last="Tian">Xia Tian</name>
<affiliation>
<nlm:affiliation>a Department of ophthalmology, Weihai Central hospital , Weihai , China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Wang, Xuehong" sort="Wang, Xuehong" uniqKey="Wang X" first="Xuehong" last="Wang">Xuehong Wang</name>
<affiliation>
<nlm:affiliation>a Department of ophthalmology, Weihai Central hospital , Weihai , China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Feng, Hui" sort="Feng, Hui" uniqKey="Feng H" first="Hui" last="Feng">Hui Feng</name>
<affiliation>
<nlm:affiliation>a Department of ophthalmology, Weihai Central hospital , Weihai , China.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Artificial cells, nanomedicine, and biotechnology</title>
<idno type="eISSN">2169-141X</idno>
<imprint>
<date when="2019" type="published">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Benzyl Alcohols (pharmacology)</term>
<term>Blood Vessels (cytology)</term>
<term>Blood Vessels (drug effects)</term>
<term>Cell Line (MeSH)</term>
<term>Endothelial Cells (cytology)</term>
<term>Endothelial Cells (drug effects)</term>
<term>Endothelial Cells (metabolism)</term>
<term>Gene Expression Regulation (drug effects)</term>
<term>Glucosides (pharmacology)</term>
<term>HMGB1 Protein (biosynthesis)</term>
<term>Humans (MeSH)</term>
<term>Inflammation (chemically induced)</term>
<term>Inflammation (pathology)</term>
<term>Intercellular Adhesion Molecule-1 (metabolism)</term>
<term>Interleukin-1beta (pharmacology)</term>
<term>Intracellular Space (drug effects)</term>
<term>Intracellular Space (metabolism)</term>
<term>L-Lactate Dehydrogenase (metabolism)</term>
<term>Mitochondria (drug effects)</term>
<term>Mitochondria (metabolism)</term>
<term>NF-kappa B (metabolism)</term>
<term>Nitric Oxide (metabolism)</term>
<term>Nitric Oxide Synthase Type III (metabolism)</term>
<term>Oxidative Stress (drug effects)</term>
<term>Reactive Oxygen Species (metabolism)</term>
<term>Retina (cytology)</term>
<term>Vascular Cell Adhesion Molecule-1 (metabolism)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="biosynthesis" xml:lang="en">
<term>HMGB1 Protein</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Intercellular Adhesion Molecule-1</term>
<term>L-Lactate Dehydrogenase</term>
<term>NF-kappa B</term>
<term>Nitric Oxide</term>
<term>Nitric Oxide Synthase Type III</term>
<term>Reactive Oxygen Species</term>
<term>Vascular Cell Adhesion Molecule-1</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Benzyl Alcohols</term>
<term>Glucosides</term>
<term>Interleukin-1beta</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en">
<term>Inflammation</term>
</keywords>
<keywords scheme="MESH" qualifier="cytology" xml:lang="en">
<term>Blood Vessels</term>
<term>Endothelial Cells</term>
<term>Retina</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Blood Vessels</term>
<term>Endothelial Cells</term>
<term>Gene Expression Regulation</term>
<term>Intracellular Space</term>
<term>Mitochondria</term>
<term>Oxidative Stress</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Endothelial Cells</term>
<term>Intracellular Space</term>
<term>Mitochondria</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Inflammation</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Cell Line</term>
<term>Humans</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Retinal endothelial cells (RECs) are involved in many ocular diseases such as age-related macular degeneration (AMD) and diabetic retinopathy. Salicin is the major ingredient of willow bark extract, and it has been shown to be a potent anti-inflammatory agent. We aim to explore whether salicin has a vascular protective effect in RECs. Our data indicate that the presence of salicin in RECs culture media ameliorates interleukin-1β (IL-1β)-induced cellular reactive oxygen species (ROS) production and NADPH oxidase 4 (NOX-4) expression. At the cellular level, salicin attenuates IL-1β-induced mitochondrial injury as revealed by its preservation on mitochondrial membrane potential (MMP). Furthermore, salicin inhibits IL-1β-induced production of pro-inflammatory cytokines such as tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and monocyte chemoattractant protein-1 (MCP-1), vascular adhesion molecules such as intercellular cell adhesion molecule-1 (iCAM-1) and vascular cell adhesion molecule 1 (VCAM-1), and high-mobility group protein 1 (HMGB-1). On the other hand, salicin recovers IL-1β-induced reduction of endothelial nitric oxide synthase (eNOS) and nitric oxide (NO) release. The presence of salicin significantly reduces the IL-1β-induced release of lactate dehydrogenase (LDH), indicating that it mitigates cytokine caused cytotoxicity. Mechanistically, we show that salicin suppresses IL-1β-induced activation of the nuclear factor-kappa B (NF-κB) signaling as revealed by its suppression on nuclear p65 protein and transfected NF-κB promoter. Collectively, our study demonstrates by multiple facets of its mechanisms that salicin is a protective agent in retinal endothelial cells. These results imply its potential use in therapeutic usage of retinal disease.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">31106593</PMID>
<DateCompleted>
<Year>2019</Year>
<Month>11</Month>
<Day>04</Day>
</DateCompleted>
<DateRevised>
<Year>2019</Year>
<Month>11</Month>
<Day>04</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">2169-141X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>47</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2019</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Artificial cells, nanomedicine, and biotechnology</Title>
<ISOAbbreviation>Artif Cells Nanomed Biotechnol</ISOAbbreviation>
</Journal>
<ArticleTitle>Vascular protection of salicin on IL-1β-induced endothelial inflammatory response and damages in retinal endothelial cells.</ArticleTitle>
<Pagination>
<MedlinePgn>1995-2002</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1080/21691401.2019.1608220</ELocationID>
<Abstract>
<AbstractText>Retinal endothelial cells (RECs) are involved in many ocular diseases such as age-related macular degeneration (AMD) and diabetic retinopathy. Salicin is the major ingredient of willow bark extract, and it has been shown to be a potent anti-inflammatory agent. We aim to explore whether salicin has a vascular protective effect in RECs. Our data indicate that the presence of salicin in RECs culture media ameliorates interleukin-1β (IL-1β)-induced cellular reactive oxygen species (ROS) production and NADPH oxidase 4 (NOX-4) expression. At the cellular level, salicin attenuates IL-1β-induced mitochondrial injury as revealed by its preservation on mitochondrial membrane potential (MMP). Furthermore, salicin inhibits IL-1β-induced production of pro-inflammatory cytokines such as tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and monocyte chemoattractant protein-1 (MCP-1), vascular adhesion molecules such as intercellular cell adhesion molecule-1 (iCAM-1) and vascular cell adhesion molecule 1 (VCAM-1), and high-mobility group protein 1 (HMGB-1). On the other hand, salicin recovers IL-1β-induced reduction of endothelial nitric oxide synthase (eNOS) and nitric oxide (NO) release. The presence of salicin significantly reduces the IL-1β-induced release of lactate dehydrogenase (LDH), indicating that it mitigates cytokine caused cytotoxicity. Mechanistically, we show that salicin suppresses IL-1β-induced activation of the nuclear factor-kappa B (NF-κB) signaling as revealed by its suppression on nuclear p65 protein and transfected NF-κB promoter. Collectively, our study demonstrates by multiple facets of its mechanisms that salicin is a protective agent in retinal endothelial cells. These results imply its potential use in therapeutic usage of retinal disease.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Song</LastName>
<ForeName>Yu</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>a Department of ophthalmology, Weihai Central hospital , Weihai , China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tian</LastName>
<ForeName>Xia</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>a Department of ophthalmology, Weihai Central hospital , Weihai , China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Xuehong</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>a Department of ophthalmology, Weihai Central hospital , Weihai , China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Feng</LastName>
<ForeName>Hui</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>a Department of ophthalmology, Weihai Central hospital , Weihai , China.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Artif Cells Nanomed Biotechnol</MedlineTA>
<NlmUniqueID>101594777</NlmUniqueID>
<ISSNLinking>2169-1401</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001592">Benzyl Alcohols</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D005960">Glucosides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D024243">HMGB1 Protein</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D053583">Interleukin-1beta</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019010">Vascular Cell Adhesion Molecule-1</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>126547-89-5</RegistryNumber>
<NameOfSubstance UI="D018799">Intercellular Adhesion Molecule-1</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>31C4KY9ESH</RegistryNumber>
<NameOfSubstance UI="D009569">Nitric Oxide</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>4649620TBZ</RegistryNumber>
<NameOfSubstance UI="C005696">salicin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.1.1.27</RegistryNumber>
<NameOfSubstance UI="D007770">L-Lactate Dehydrogenase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.14.13.39</RegistryNumber>
<NameOfSubstance UI="D052250">Nitric Oxide Synthase Type III</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D001592" MajorTopicYN="N">Benzyl Alcohols</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001808" MajorTopicYN="N">Blood Vessels</DescriptorName>
<QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D042783" MajorTopicYN="N">Endothelial Cells</DescriptorName>
<QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005960" MajorTopicYN="N">Glucosides</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D024243" MajorTopicYN="N">HMGB1 Protein</DescriptorName>
<QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName>
<QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018799" MajorTopicYN="N">Intercellular Adhesion Molecule-1</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D053583" MajorTopicYN="N">Interleukin-1beta</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D042541" MajorTopicYN="N">Intracellular Space</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007770" MajorTopicYN="N">L-Lactate Dehydrogenase</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009569" MajorTopicYN="N">Nitric Oxide</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D052250" MajorTopicYN="N">Nitric Oxide Synthase Type III</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012160" MajorTopicYN="N">Retina</DescriptorName>
<QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019010" MajorTopicYN="N">Vascular Cell Adhesion Molecule-1</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">IL-1β</Keyword>
<Keyword MajorTopicYN="N">NF-κB</Keyword>
<Keyword MajorTopicYN="N">Retinal endothelial cell (RECs)</Keyword>
<Keyword MajorTopicYN="N">inflammation</Keyword>
<Keyword MajorTopicYN="N">reactive oxygen species (ROS)</Keyword>
<Keyword MajorTopicYN="N">salicin</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2019</Year>
<Month>5</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2019</Year>
<Month>5</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2019</Year>
<Month>11</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">31106593</ArticleId>
<ArticleId IdType="doi">10.1080/21691401.2019.1608220</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/WillowV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000452 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000452 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    WillowV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:31106593
   |texte=   Vascular protection of salicin on IL-1β-induced endothelial inflammatory response and damages in retinal endothelial cells.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:31106593" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a WillowV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Tue Nov 17 16:35:40 2020. Site generation: Tue Nov 17 16:39:32 2020